Spinal biologics is rapidly evolving and being recognized for its potential to treat challenging painful conditions. However, the indications, risks, and concerns regarding biologics for a variety of spinal conditions have not been agreed upon.

On April 21 in Chicago, NASS will present the course, Biologic Interventions for Spinal Pathologies: Stem Cells, Growth Factors and Novel Therapeutics. The comprehensive one-day course is co-chaired by Raymond J. Hah, MD and Zorica Buser, PhD, MBA, and will feature experts from academia and industry discussing the pertinent technologies, relevant issues, and latest updates for 2023 regarding biologics use for spinal conditions. View the Agenda.

All spine professionals with an interest in spinal biologics are invited to attend this course, held at The Drake Hotel in Chicago. The NASS special hotel savings discount at The Drake will end on March 30.

For more information and to register click here.

---